arrow
An-Wen Chan 封面图

An-Wen Chan

University of Toronto教授
H指数:55
被引数:4.3万

个人简介

Holds the position of Phelan Professor at Women’s College Research Institute and Associate Professor of Medicine at University of Toronto. The scholar obtained a DPhil as a Rhodes Scholar at University of Oxford, completed a dermatology residency at University of Toronto, and a Mohs micrographic surgery fellowship at Mayo Clinic, Rochester. Currently serving as the research director for the University of Toronto dermatology residency program, the scholar focuses on clinical trials as well as the prevention, detection, and treatment of high-risk skin cancers. Academic honors include service as a director of the International Transplant Skin Cancer Collaborative, Special Advisor to the Canadian Institutes of Health Research, and coordinating scientist for the World Health Organization’s International Clinical Trials Registry Platform.

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

  1. Rhodes Scholar
CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trials

CONSORT-Children and Adolescents (CONSORT-C) 2026扩展声明:提升儿科随机试验的报告质量和影响力

2026-02-240
PRE
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocols

SPIRIT-Children and Adolescents (SPIRIT-C) 2026扩展声明:增强儿科随机试验方案的报告和实用性

2026-02-240
PRE
Reporting of environmental outcomes in randomised clinical trials: a protocol for a scoping review

随机对照试验中环境结果的报告:一项范围研究的方案

2025-09-230
OAAI
Protocol for development of SPIRIT and CONSORT extensions for reporting climate and environmental outcomes in randomised trials (SPIRIT-ICE and CONSORT-ICE)

SPIRIT-ICE和CONSORT-ICE的开发协议:随机试验中报告气候和环境结果的SPIRIT与CONSORT扩展方案

2025-09-210
OAAI
Reporting guideline for chatbot health advice studies: The CHART statement

聊天机器人健康建议研究汇报规范:CHART声明

2025-08-010
OA
CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials

CONSORT 2025声明:随机试验报告更新指南

2025-06-102
PRE
Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelines (vol 15, 1619 , 2024)
2024-07-290
OAAI
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration
2024-07-099
OAAI
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration
2024-07-095
OAAI